GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aadi Bioscience Inc (STU:3350) » Definitions » ROIC %

Aadi Bioscience (STU:3350) ROIC % : -723.47% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Aadi Bioscience ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Aadi Bioscience's annualized return on invested capital (ROIC %) for the quarter that ended in Mar. 2024 was -723.47%.

As of today (2024-06-02), Aadi Bioscience's WACC % is 10.70%. Aadi Bioscience's ROIC % is -744.58% (calculated using TTM income statement data). Aadi Bioscience earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Aadi Bioscience ROIC % Historical Data

The historical data trend for Aadi Bioscience's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aadi Bioscience ROIC % Chart

Aadi Bioscience Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROIC %
-25.53 -423.24 -662.99 -662.55

Aadi Bioscience Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -756.30 -908.36 -688.87 -616.88 -723.47

Competitive Comparison of Aadi Bioscience's ROIC %

For the Biotechnology subindustry, Aadi Bioscience's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aadi Bioscience's ROIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aadi Bioscience's ROIC % distribution charts can be found below:

* The bar in red indicates where Aadi Bioscience's ROIC % falls into.



Aadi Bioscience ROIC % Calculation

Aadi Bioscience's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2023 is calculated as:

ROIC % (A: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2022 ) + Invested Capital (A: Dec. 2023 ))/ count )
=-65.963 * ( 1 - 0% )/( (9.502 + 10.41)/ 2 )
=-65.963/9.956
=-662.55 %

where

Aadi Bioscience's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Mar. 2024 is calculated as:

ROIC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=-71.804 * ( 1 - 0% )/( (10.41 + 9.44)/ 2 )
=-71.804/9.925
=-723.47 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aadi Bioscience  (STU:3350) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Aadi Bioscience's WACC % is 10.70%. Aadi Bioscience's ROIC % is -744.58% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Aadi Bioscience ROIC % Related Terms

Thank you for viewing the detailed overview of Aadi Bioscience's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aadi Bioscience (STU:3350) Business Description

Traded in Other Exchanges
Address
17383 Sunset Boulevard, Suite A250, Pacific Palisades, CA, USA, 90272
Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

Aadi Bioscience (STU:3350) Headlines

No Headlines